BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 33080858)

  • 1. miRNA Expression Profiles in Luminal A Breast Cancer-Implications in Biology, Prognosis, and Prediction of Response to Hormonal Treatment.
    Kudela E; Samec M; Koklesova L; Liskova A; Kubatka P; Kozubik E; Rokos T; Pribulova T; Gabonova E; Smolar M; Biringer K
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33080858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of micrornas in molecular genetic breast cancer subtypes.
    Kolesnikov NN; Veryaskina YA; Titov SE; Rodionov VV; Gening TP; Abakumova TV; Kometova VV; Torosyan MK; Zhimulev IF
    Cancer Treat Res Commun; 2019; 20():100026. PubMed ID: 31255253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential distribution of microRNAs in breast cancer grouped by clinicopathological subtypes.
    Li JY; Jia S; Zhang WH; Zhang Y; Kang Y; Li PS
    Asian Pac J Cancer Prev; 2013; 14(5):3197-203. PubMed ID: 23803104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miRNA in a multiomic context for diagnosis, treatment monitoring and personalized management of metastatic breast cancer.
    Zubor P; Kubatka P; Dankova Z; Gondova A; Kajo K; Hatok J; Samec M; Jagelkova M; Krivus S; Holubekova V; Bujnak J; Laucekova Z; Zelinova K; Stastny I; Nachajova M; Danko J; Golubnitschaja O
    Future Oncol; 2018 Aug; 14(18):1847-1867. PubMed ID: 30019928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosomal miRNA profile as complementary tool in the diagnostic and prediction of treatment response in localized breast cancer under neoadjuvant chemotherapy.
    Rodríguez-Martínez A; de Miguel-Pérez D; Ortega FG; García-Puche JL; Robles-Fernández I; Exposito J; Martorell-Marugan J; Carmona-Sáez P; Garrido-Navas MDC; Rolfo C; Ilyine H; Lorente JA; Legueren M; Serrano MJ
    Breast Cancer Res; 2019 Feb; 21(1):21. PubMed ID: 30728048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metastatic breast cancer: the potential of miRNA for diagnosis and treatment monitoring.
    McGuire A; Brown JA; Kerin MJ
    Cancer Metastasis Rev; 2015 Mar; 34(1):145-55. PubMed ID: 25721950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysregulation of microRNAs in breast cancer and their potential role as prognostic and predictive biomarkers in patient management.
    van Schooneveld E; Wildiers H; Vergote I; Vermeulen PB; Dirix LY; Van Laere SJ
    Breast Cancer Res; 2015 Feb; 17():21. PubMed ID: 25849621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA expression and gene regulation drive breast cancer progression and metastasis in PyMT mice.
    Nogales-Cadenas R; Cai Y; Lin JR; Zhang Q; Zhang W; Montagna C; Zhang ZD
    Breast Cancer Res; 2016 Jul; 18(1):75. PubMed ID: 27449149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene co-expression network approach for predicting prognostic microRNA biomarkers in different subtypes of breast cancer.
    Adhami M; MotieGhader H; Haghdoost AA; Afshar RM; Sadeghi B
    Genomics; 2020 Jan; 112(1):135-143. PubMed ID: 30735795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrence prediction using microRNA expression in hormone receptor positive breast cancer during tamoxifen treatment.
    Kim C; Go EJ; Kim A
    Biomarkers; 2018 Dec; 23(8):804-811. PubMed ID: 30010434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BreastMark: an integrated approach to mining publicly available transcriptomic datasets relating to breast cancer outcome.
    Madden SF; Clarke C; Gaule P; Aherne ST; O'Donovan N; Clynes M; Crown J; Gallagher WM
    Breast Cancer Res; 2013; 15(4):R52. PubMed ID: 23820017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of blood-based miRNAs as diagnostic and prognostic nucleic acid markers in breast cancer: Comparative to conventional tumor markers.
    Swellam M; Ramadan A; El-Hussieny EA; Bakr NM; Hassan NM; Sobeih ME; EzzElArab LR
    J Cell Biochem; 2019 Aug; 120(8):12321-12330. PubMed ID: 30825229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs as biomarkers for early breast cancer diagnosis, prognosis and therapy prediction.
    Nassar FJ; Nasr R; Talhouk R
    Pharmacol Ther; 2017 Apr; 172():34-49. PubMed ID: 27916656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miRpower: a web-tool to validate survival-associated miRNAs utilizing expression data from 2178 breast cancer patients.
    Lánczky A; Nagy Á; Bottai G; Munkácsy G; Szabó A; Santarpia L; Győrffy B
    Breast Cancer Res Treat; 2016 Dec; 160(3):439-446. PubMed ID: 27744485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Value of a BCSC-associated MicroRNA Signature in Hormone Receptor-Positive HER2-Negative Breast Cancer.
    Gong C; Tan W; Chen K; You N; Zhu S; Liang G; Xie X; Li Q; Zeng Y; Ouyang N; Li Z; Zeng M; Zhuang S; Lau WY; Liu Q; Yin D; Wang X; Su F; Song E
    EBioMedicine; 2016 Sep; 11():199-209. PubMed ID: 27566954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-free miRNAs as non-invasive biomarkers in breast cancer: Significance in early diagnosis and metastasis prediction.
    Kashyap D; Kaur H
    Life Sci; 2020 Apr; 246():117417. PubMed ID: 32044304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secreted breast tumor interstitial fluid microRNAs and their target genes are associated with triple-negative breast cancer, tumor grade, and immune infiltration.
    Terkelsen T; Russo F; Gromov P; Haakensen VD; Brunak S; Gromova I; Krogh A; Papaleo E
    Breast Cancer Res; 2020 Jun; 22(1):73. PubMed ID: 32605588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic and therapeutic application of microRNAs in breast cancer: Tissue and circulating microRNAs.
    Bahrami A; Aledavood A; Anvari K; Hassanian SM; Maftouh M; Yaghobzade A; Salarzaee O; ShahidSales S; Avan A
    J Cell Physiol; 2018 Feb; 233(2):774-786. PubMed ID: 28109133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of microRNAs in Nipple Discharge as Potential Diagnostic Biomarkers for Breast Cancer.
    Zhang K; Zhao S; Wang Q; Yang HS; Zhu J; Ma R
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S536-44. PubMed ID: 25976861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the miRNA-mRNA-lncRNA network in human estrogen receptor-positive and estrogen receptor-negative breast cancer based on TCGA data.
    Xiao B; Zhang W; Chen L; Hang J; Wang L; Zhang R; Liao Y; Chen J; Ma Q; Sun Z; Li L
    Gene; 2018 Jun; 658():28-35. PubMed ID: 29518546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.